Erratum: Glucocorticoid-Induced Osteoporosis Program (GIOP): A novel, comprehensive, and highly successful care program with improved outcomes at 1 year (Osteoporosis International DOI: 10.1007/s00198-006-0149-3);Glucocorticoid-Induced Osteoporosis Program (GIOP): A novel, comprehensive, and highly successful care program with improved outcomes at 1 year

Osteoporosis International

Volumn 17, Issue 9, 2006, Pages 1428-1434

  Newman, E D ^a   Matzko, C K ^a   Olenginski, T P ^a   Perruquet, J L ^a   Harrington, T M ^a   Maloney Saxon, G ^a   Culp, T ^a   Wood, G C ^b  

^a GEISINGER MEDICAL CENTER   (United States)

^b GEISINGER HEALTH SYSTEM   (United States)

Author keywords

Glucocorticoid; Osteoporosis; Outcomes; Program

Indexed keywords

25 HYDROXYVITAMIN D; ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; GLUCOCORTICOID; PARATHYROID HORMONE[1-34]; RECOMBINANT PARATHYROID HORMONE; RISEDRONIC ACID; VITAMIN D;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE FRAGILITY; CONTROLLED STUDY; EXERCISE; FEMALE; FOLLOW UP; FRACTURE; HEALTH CARE SYSTEM; HIP; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PRESCRIPTION; PRIORITY JOURNAL; RISK; SPINE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 33746400105     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-006-0198-7     Document Type: Erratum

References (23)

1. Saag KG (2003) Glucocorticoid-induced osteoporosis. Endocrinol Metab Clin N Am 32:135-157
2. Cohen D, Adachi JD (2004) The treatment of glucocorticoid-induced osteoporosis. J Steroid Biochem Mol Biol 88:337-349
3. American College of Rheumatology Ad Hoc Committee on Glucocorticoid- induced Osteoporosis (2001) Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 44:1496-1503
4. Brown JP, Josse RG (2002) 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167(10 Suppl):S1-S30
5. Eastell R, Reid DM, Compston J et al (1998) A UK consensus group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med 244:271-292
6. Solomon DH, Katz JN, Jacobs JP, La Tourette AM, Coblyn J (2002) Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis. Arthritis Rheum 46:3136-3142
7. Blalock SJ, Norton LL, Patel RA, Dooley MA (2005) Patient knowledge, beliefs, and behavior concerning the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 53:732-739
8. Naunton M, Peterson GM, Jones G, Griffin GM, Bleasel MD (2004) Multifaceted educational program increase prescribing of preventive medication for corticosteroid induced osteoporosis. J Rheumatol 31:550-556
9. Solomon DH, Katz JN, La Tourette AM, Coblyn JS (2004) Multifaceted intervention to improve rheumatologists' management of glucocorticoid-induced osteoporosis: a randomized controlled trial. Arthritis Rheum 51:383-387
10. Newman ED, Ayoub WT, Starkey RH, Diehl JM, Wood GC (2003) Osteoporosis disease management in a rural health care population: hip fracture reduction and reduced costs in postmenopausal women after 5 years. Osteoporos Int 14:146-151
11. Newman ED, Ayoub WT, Matzko CK, Wood C (2003) Glucocorticoid-induced osteoporosis-significant improvement in bisphosphonate use utilizing standardized consultative DXA reporting. Arthritis Rheum 48:8499
12. Canalis E, Bilezikian JP, Angeli A, Giustina A (2004) Perspectives on glucocorticoid-induced osteoporosis. Bone 34:593-598
13. Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993-1000
14. Sambrook PN (2002) Glucocorticoid osteoporosis. Curr Pharm Des 8:1877-1883
15. Homik JJ, Cranney A, Shea BJ et al (2005) Calcium and vitamin D for corticosteroid-induced osteoporosis (Cochrane Review) (2005) In: The cochrane library, Issue 4. Wiley, Chichester, UK
16. Lane NE (2001) An update on glucocorticoid-induced osteoporosis. Rheum Dis Clin North Am 27:235-253
17. Reid IR (2000) Glucocorticoid-induced osteoporosis. Baillieres Clin Endocrinol Metab 14:279-298
18. Sambrook PN (2005) How to prevent steroid induced osteoporosis. Ann Rheum Dis 64:176-178
19. Adachi JD, Saag KG, Delmas PD et al (2001) Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids -a randomized, double-blind, placebo-controlled extension trial. Arthritis Rheum 44:202-211
20. Cohen S, Levy RM, Keller M et al (1999) Risedronate therapy prevents corticosteroid-induced bone loss -a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel group study. Arthritis Rheum 42:2309-2318
21. Lane NE, Sanchez S, Modin G et al (2000) Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled trial. J Bone Miner Res 15:944-951
22. Curtis JR, Westfall AO, Allison JJ et al (2005) Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum 52:2486-2494
23. Harrington JT, Barash HL, Day S, Lease J (2005) Redesigning the care of fragility fracture patients to improve osteoporosis management: a health care improvement project. Arthritis Rheum 53:198-204